Drug prices' Drug prices'
Stories About

Drug prices'

The Trump administration has suggested buying a prescription drug is like buying a car — with plenty of room to negotiate down from the sticker price. But drug pricing analysts say the analogy doesn't work. tomeng/Getty Images hide caption

toggle caption
tomeng/Getty Images

How Does Drug Pricing Work? Hint: It's More Like Designer Handbags Than Cars

  • Download
  • <iframe src="https://www.npr.org/player/embed/742436138/742819034" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Physicians complain that there's not yet a standard drug-pricing tool available to them that includes the range of medicine prices each of their patients might face — one that takes into account their particular pharmacy choice and health insurance plan. Exdez/Getty Images hide caption

toggle caption
Exdez/Getty Images

Jake Powell, who works in New York City, is originally from Wyoming. Powell joined the PrEP4All movement after having to go off the drug for six months because it was too costly, even for someone with health insurance. Courtesy of Brandon Cuicchi hide caption

toggle caption
Courtesy of Brandon Cuicchi

AIDS Activists Take Aim At Gilead To Lower Price Of HIV Drug PrEP

  • <iframe src="https://www.npr.org/player/embed/727731380/728239771" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

"It shouldn't have happened," says Nicole Smith-Holt of Richfield, Minn., gazing at the death certificate of her son Alec Raeshawn Smith. Bram Sable-Smith for NPR hide caption

toggle caption
Bram Sable-Smith for NPR

Insulin's High Cost Leads To Lethal Rationing

  • Download
  • <iframe src="https://www.npr.org/player/embed/641615877/643922073" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

French pharmaceutical group Sanofi is expected to receive an exclusive license to market a new Zika vaccine. AFP/AFP/Getty Images hide caption

toggle caption
AFP/AFP/Getty Images

States Fear Price Of New Zika Vaccine Will Be More Than They Can Pay

  • Download
  • <iframe src="https://www.npr.org/player/embed/529887446/530697999" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Gilead Sciences Inc. makes the two leading drugs that can quickly cure hepatitis C infections. But most patients can't afford the expensive drugs, and states restrict their use among Medicaid patients. David Paul Morris/Bloomberg via Getty Images hide caption

toggle caption
David Paul Morris/Bloomberg via Getty Images

Should The U.S. Government Buy A Drug Company To Save Money?

  • Download
  • <iframe src="https://www.npr.org/player/embed/520430944/520576934" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

An aggressive marketing campaign has made the EpiPen the go-to drug for treating anaphylaxis. Mark Zaleski/AP hide caption

toggle caption
Mark Zaleski/AP

EpiPen Manufacturer Says It Will Help With Out-Of-Pocket Costs

  • Download
  • <iframe src="https://www.npr.org/player/embed/491232665/491311810" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Tim Kilroy runs a business from his home in Arlington, Mass. His insurance company quit covering the long-acting Ritalin that helps him manage his ADHD. Ellen Webber for NPR hide caption

toggle caption
Ellen Webber for NPR

Fight To Lower Drug Prices Forces Some To Switch Medication

  • Download
  • <iframe src="https://www.npr.org/player/embed/463809474/464266304" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
Maria Fabrizio for NPR

Multiple Sclerosis Patients Stressed Out By Soaring Drug Costs

  • Download
  • <iframe src="https://www.npr.org/player/embed/408021704/409421455" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

New hepatitis C drugs can cost as much as $1,000 per pill. Katherine Streeter for NPR hide caption

toggle caption
Katherine Streeter for NPR

Medicare Won't Always Pay For Boomers' Pricey Hepatitis C Drugs

  • Download
  • <iframe src="https://www.npr.org/player/embed/307747798/311760028" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript